Related Experiment Video

Updated: Aug 22, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Mechanisms of tumor evasion from the immune response

Paulo C Rodríguez1, Arnold H Zea, Augusto C Ochoa

  • 1Stanley S. Scott Cancer Center, Pediatrics Department, Louisiana State University Health Sciences Center, New Orleans 70112, USA.

Cancer Chemotherapy and Biological Response Modifiers
|September 2, 2004
PubMed

Insights

Tumors employ diverse strategies to evade the immune system, impacting cancer progression and immunotherapy effectiveness. Understanding these immune evasion mechanisms is crucial for developing novel cancer treatments.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Tumors exhibit multiple mechanisms to evade immune system detection and destruction.
  • These evasion strategies occur throughout tumor development, from early stages to progressive growth.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms by which tumors evade the immune response.
  • To explore the correlation between tumor immune evasion and clinical outcomes, including metastasis and immunotherapy response.

Main Methods:

  • In vitro immunological experiments
  • Murine tumor models
  • Analysis of patient cancer samples

Main Results:

  • Tumors evade the innate immune response by being poor stimulators, poor targets, or resistant.
  • Progressively growing tumors impair adaptive immunity by affecting antigen-presenting cells (APCs) and T-cell function.
  • Tumor immune evasion correlates with increased metastatic potential, reduced immunotherapy response, and poor prognosis.

Conclusions:

  • Understanding tumor immune evasion is key to improving cancer immunotherapy.
  • Further research is needed to fully determine the impact of these mechanisms on disease outcome and treatment response.
  • Elucidating these mechanisms may lead to new therapeutic strategies to reverse immune alterations and enhance immunotherapy efficacy.

More Related Videos

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Published on: January 26, 2024

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...